Skip to main content
. 2022 Mar 23;49(9):3247–3256. doi: 10.1007/s00259-022-05762-4

Table 1.

Summary of findings table presenting the results of the GRADE synthesis and rating process. Table created with the GRADEpro Guideline Development Tool: GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University, 2020 (developed by Evidence Prime, Inc.). Available from gradepro.org. Table modified. Full information presented in Online Resource 4

Certainty assessment Certainty
No of studies Study design Risk of bias Inconsistency Indirectness Imprecision Other considerations
Second primary malignancies
8 Observational studies Serious Not serious Not serious Serious Dose–response gradient

⨁◯◯◯

VERY LOW

Secondary hematologic malignancies
3 Observational studies Not serious Not serious Not serious Serious Dose–response gradient

⨁⨁◯◯

LOW

Dose response gradient
8 Observational studies Serious Not serious Not serious Serious Dose–response gradient

⨁◯◯◯

VERY LOW